Press releases
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
3rd May 2022
Latest news, Events and Press Releases
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
Please direct any media inquiries to Camilla Campbell, VP Communications at camilla.campbell@curiumpharma.com.
Press releases
Press releases
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
19th April 2022
Press releases
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
5th April 2022
Press releases
Curium to become major player in the supply on non carrier added Lu-177
25th January 2022
Press releases
Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer
15th December 2021
Press releases
Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
27th October 2021
Press releases
Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
24th August 2021
Press releases
Curium Acquires Austrian Radiopharmaceuticals Company IASON
1st June 2021
Press releases
RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
5th May 2021
Press releases
Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
4th May 2021
Press releases
Curium to Expand Noblesville Facility’s Workforce
28th April 2021
Press releases
RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)
23rd March 2021